Beryl Drugs Ltd.

Beryl Drugs Ltd. (NSE/BSE: BERLDRG) is an Indian publicly listed company quoted on the Bombay Stock Exchange (BSE). The company operates in healthcare, a sector that combines regulated pricing with long-run demand growth from a rising domestic patient base. Its securities trade under ISIN INE415H01017. As of the most recent update, Beryl Drugs Ltd. carries an equity market capitalisation of approximately ₹15.46 Cr, which places it among the tracked constituents of the Healthcare sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by Beryl Drugs Ltd. via stock-exchange filings. For investors and researchers tracking healthcare listings, BERLDRG provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates Beryl Drugs Ltd.'s core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.